My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 118

    1.

    Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes.

    Stefansson OA, Jonasson JG, Johannsson OT, Olafsdottir K, Steinarsdottir M, Valgeirsdottir S, Eyfjord JE.

    Breast Cancer Res. 2009;11(4):R47. Epub 2009 Jul 9. Erratum in: Breast Cancer Res. 2009;11(5):404. PMID: 19589159 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer.

    Birgisdottir V, Stefansson OA, Bodvarsdottir SK, Hilmarsdottir H, Jonasson JG, Eyfjord JE.

    Breast Cancer Res. 2006;8(4):R38.PMID: 16846527 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Estrogen receptor status could modulate the genomic pattern in familial and sporadic breast cancer.

    Melchor L, Honrado E, Huang J, Alvarez S, Naylor TL, García MJ, Osorio A, Blesa D, Stratton MR, Weber BL, Cigudosa JC, Rahman N, Nathanson KL, Benítez J.

    Clin Cancer Res. 2007 Dec 15;13(24):7305-13.PMID: 18094411 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors.

    Bane AL, Pinnaduwage D, Colby S, Bull SB, O'Malley FP, Andrulis IL.

    Breast Cancer Res Treat. 2009 Sep;117(1):183-91. Epub 2008 Jun 18.PMID: 18563556 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization.

    Jönsson G, Naylor TL, Vallon-Christersson J, Staaf J, Huang J, Ward MR, Greshock JD, Luts L, Olsson H, Rahman N, Stratton M, Ringnér M, Borg A, Weber BL.

    Cancer Res. 2005 Sep 1;65(17):7612-21.PMID: 16140926 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    An integrative hypothesis about the origin and development of sporadic and familial breast cancer subtypes.

    Melchor L, Benítez J.

    Carcinogenesis. 2008 Aug;29(8):1475-82. Epub 2008 Jul 1. Review.PMID: 18596026 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas.

    Rodríguez-Pinilla SM, Sarrió D, Honrado E, Moreno-Bueno G, Hardisson D, Calero F, Benítez J, Palacios J.

    J Clin Pathol. 2007 Sep;60(9):1006-12. Epub 2006 Nov 14.PMID: 17105822 [PubMed - indexed for MEDLINE]Related articles

    8.

    Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes.

    Melchor L, Honrado E, García MJ, Alvarez S, Palacios J, Osorio A, Nathanson KL, Benítez J.

    Oncogene. 2008 May 15;27(22):3165-75. Epub 2007 Dec 10.PMID: 18071313 [PubMed - indexed for MEDLINE]Related articles

    9.

    Familial breast cancers without mutations in BRCA1 or BRCA2 have low cyclin E and high cyclin D1 in contrast to cancers in BRCA mutation carriers.

    Aaltonen K, Blomqvist C, Amini RM, Eerola H, Aittomäki K, Heikkilä P, Nevanlinna H.

    Clin Cancer Res. 2008 Apr 1;14(7):1976-83.PMID: 18381935 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families.

    Eerola H, Heinonen M, Heikkilä P, Kilpivaara O, Tamminen A, Aittomäki K, Blomqvist C, Ristimäki A, Nevanlinna H.

    Breast Cancer Res. 2008;10(1):R17. Epub 2008 Feb 14.PMID: 18275599 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Hereditary breast cancer: pathobiology, clinical translation, and potential for targeted cancer therapeutics.

    Rubinstein WS.

    Fam Cancer. 2008;7(1):83-9. Epub 2007 Jul 12. Review.PMID: 17624601 [PubMed - indexed for MEDLINE]Related articles

    12.

    Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations.

    van Beers EH, van Welsem T, Wessels LF, Li Y, Oldenburg RA, Devilee P, Cornelisse CJ, Verhoef S, Hogervorst FB, van't Veer LJ, Nederlof PM.

    Cancer Res. 2005 Feb 1;65(3):822-7.PMID: 15705879 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.

    Hedau S, Jain N, Husain SA, Mandal AK, Ray G, Shahid M, Kant R, Gupta V, Shukla NK, Deo SS, Das BC.

    Breast Cancer Res Treat. 2004 Nov;88(2):177-86.PMID: 15564800 [PubMed - indexed for MEDLINE]Related articles

    14.

    Molecular classification of familial non-BRCA1/BRCA2 breast cancer.

    Hedenfalk I, Ringner M, Ben-Dor A, Yakhini Z, Chen Y, Chebil G, Ach R, Loman N, Olsson H, Meltzer P, Borg A, Trent J.

    Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2532-7. Epub 2003 Feb 27.PMID: 12610208 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germ-line mutation carriers and vice versa.

    Staff S, Isola JJ, Johannsson O, Borg A, Tanner MM.

    Br J Cancer. 2001 Oct 19;85(8):1201-5.PMID: 11710835 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    p53 inactivation is a rare event in familial breast tumors negative for BRCA1 and BRCA2 mutations.

    Sensi E, Tancredi M, Aretini P, Cipollini G, Naccarato AG, Viacava P, Bevilacqua G, Caligo MA.

    Breast Cancer Res Treat. 2003 Nov;82(1):1-9.PMID: 14672397 [PubMed - indexed for MEDLINE]Related articles

    17.

    Molecular profile of ductal carcinoma in situ of the breast in BRCA1 and BRCA2 germline mutation carriers.

    van der Groep P, van Diest PJ, Menko FH, Bart J, de Vries EG, van der Wall E.

    J Clin Pathol. 2009 Oct;62(10):926-30. Epub 2009 Jun 18.PMID: 19541683 [PubMed - indexed for MEDLINE]Related articles

    18.

    Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers.

    Jazaeri AA, Yee CJ, Sotiriou C, Brantley KR, Boyd J, Liu ET.

    J Natl Cancer Inst. 2002 Jul 3;94(13):990-1000.PMID: 12096084 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families.

    Eerola H, Heikkilä P, Tamminen A, Aittomäki K, Blomqvist C, Nevanlinna H.

    Breast Cancer Res. 2005;7(4):R465-9. Epub 2005 Apr 21.PMID: 15987451 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.

    Palacios J, Honrado E, Osorio A, Cazorla A, Sarrió D, Barroso A, Rodríguez S, Cigudosa JC, Diez O, Alonso C, Lerma E, Sánchez L, Rivas C, Benítez J.

    Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3606-14.PMID: 14506147 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk